BRAF inhibitors for the treatment of metastatic melanoma: clinical trials and mechanisms of resistance
AM Alcalá, KT Flaherty - Clinical cancer research, 2012 - AACR
The efficacy of selective BRAF inhibitors has now been established in the 50% of patients
with metastatic melanoma whose tumors harbor activating mutations. However, for the vast …
with metastatic melanoma whose tumors harbor activating mutations. However, for the vast …
[PDF][PDF] BRAF Inhibitors for the Treatment of Metastatic Melanoma: Clinical Trials and Mechanisms of Resistance
AM Alcalá, KT Flaherty - Clin Cancer Res, 2012 - scholar.archive.org
The efficacy of selective BRAF inhibitors has now been established in the 50% of patients
with metastatic melanoma whose tumors harbor activating mutations. However, for the vast …
with metastatic melanoma whose tumors harbor activating mutations. However, for the vast …
BRAF inhibitors for the treatment of metastatic melanoma: clinical trials and mechanisms of resistance
AM Alcalá, KT Flaherty - … research: an official journal of the …, 2012 - pubmed.ncbi.nlm.nih.gov
The efficacy of selective BRAF inhibitors has now been established in the 50% of patients
with metastatic melanoma whose tumors harbor activating mutations. However, for the vast …
with metastatic melanoma whose tumors harbor activating mutations. However, for the vast …
BRAF inhibitors for the treatment of metastatic melanoma: clinical trials and mechanisms of resistance.
AM Alcalá, KT Flaherty - … Cancer Research: an Official Journal of …, 2012 - europepmc.org
The efficacy of selective BRAF inhibitors has now been established in the 50% of patients
with metastatic melanoma whose tumors harbor activating mutations. However, for the vast …
with metastatic melanoma whose tumors harbor activating mutations. However, for the vast …
[引用][C] BRAF Inhibitors for the Treatment of Metastatic Melanoma: Clinical Trials and Mechanisms of Resistance
AM Alcalá, KT Flaherty - Clinical Cancer Research, 2012 - cir.nii.ac.jp
BRAF Inhibitors for the Treatment of Metastatic Melanoma: Clinical Trials and Mechanisms of
Resistance | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …
Resistance | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …
[引用][C] BRAF Inhibitors for the Treatment of Metastatic Melanoma: Clinical Trials and Mechanisms of Resistance: Drug Development: What Experience Has Taught Us
A MARZUKA ALCALA… - Clinical cancer research …, 2012 - pascal-francis.inist.fr
BRAF Inhibitors for the Treatment of Metastatic Melanoma: Clinical Trials and Mechanisms of
Resistance : Drug Development: What Experience Has Taught Us CNRS Inist Pascal-Francis …
Resistance : Drug Development: What Experience Has Taught Us CNRS Inist Pascal-Francis …